Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Dan H, Barouch"'
Autor:
Aurélien vander Straeten, Morteza Sarmadi, John L. Daristotle, Maria Kanelli, Lisa H. Tostanoski, Joe Collins, Apurva Pardeshi, Jooli Han, Dhruv Varshney, Behnaz Eshaghi, Johnny Garcia, Timothy A. Forster, Gary Li, Nandita Menon, Sydney L. Pyon, Linzixuan Zhang, Catherine Jacob-Dolan, Olivia C. Powers, Kevin Hall, Shahad K. Alsaiari, Morris Wolf, Mark W. Tibbitt, Robert Farra, Dan H. Barouch, Robert Langer, Ana Jaklenec
Publikováno v:
Nature Biotechnology.
Autor:
Laura Solforosi, Lea M. M. Costes, Jeroen T. B. M. Tolboom, Katherine McMahan, Tochi Anioke, David Hope, Tetyana Murdza, Michaela Sciacca, Emily Bouffard, Julia Barrett, Cindy Wu, Nicole Hachmann, Jessica Miller, Jingyou Yu, Xuan He, Catherine Jacob-Dolan, Sietske K. Rosendahl Huber, Liesbeth Dekking, Ronnie Chamanza, Ying Choi, Karin Feddes-de Boer, Dan H. Barouch, Hanneke Schuitemaker, Roland C. Zahn, Frank Wegmann
Publikováno v:
Nature Communications. 14
Omicron spike (S) encoding vaccines as boosters, are a potential strategy to improve COVID-19 vaccine efficacy against Omicron. Here, macaques (mostly females) previously immunized with Ad26.COV2.S, are boosted with Ad26.COV2.S, Ad26.COV2.S.529 (enco
Autor:
Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray-Arce, Kijun Song, Andrew Z. Xu, Soumik Barman, Manisha Menon, Danica Dong, Timothy M. Caradonna, Jared Feldman, Blake M. Hauser, Aaron G. Schmidt, Lindsey R. Baden, Robert K. Ernst, Carly Dillen, Jingyou Yu, Aiquan Chang, Luuk Hilgers, Peter Paul Platenburg, Sirano Dhe-Paganon, Dan H. Barouch, Al Ozonoff, Ivan Zanoni, Matthew B. Frieman, David J. Dowling, Ofer Levy
Publikováno v:
npj Vaccines. 8
Autor:
Catherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, Victoria Giffin, Abishek Chandrashekar, Amanda J. Martinot, Tochi Anioke, Olivia C. Powers, Kevin Hall, David Hope, Jessica Miller, Nichole P. Hachmann, Benjamin Chung, Sarah Gardner, Daniel Sellers, Julia Barrett, Mark G. Lewis, Hanne Andersen, Harry Kleanthous, Ki-Woen Seo, Su Jeen Lee, Yong Wook Park, Hun Kim, Dan H. Barouch
Publikováno v:
npj Vaccines. 8
Despite the availability of several effective SARS-CoV-2 vaccines, additional vaccines will be required for optimal global vaccination. In this study, we investigate the immunogenicity and protective efficacy of the GBP510 protein subunit vaccine adj
Autor:
Etsuro Nanishi, Francesco Borriello, Hyuk-Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray-Arce, Kijun Song, Andrew Z. Xu, Soumik Barman, Manisha Menon, Danica Dong, Timothy M. Caradonna, Jared Feldman, Blake M. Hauser, Aaron G. Schmidt, Lindsey R. Baden, Robert K. Ernst, Carly Dillen, Jingyou Yu, Aiquan Chang, Luuk Hilgers, Peter Paul Platenburg, Sirano Dhe-Paganon, Dan H. Barouch, Al Ozonoff, Ivan Zanoni, Matthew B. Frieman, David J. Dowling, Ofer Levy
Publikováno v:
npj Vaccines. 8
Development of SARS-CoV-2 vaccines that protect vulnerable populations is a public health priority. Here, we took a systematic and iterative approach by testing several adjuvants and SARS-CoV-2 antigens to identify a combination that elicits antibodi
Autor:
Ai-ris Y. Collier, Anna M. Modest, Ricardo A. Aguayo, Esther A. Bondzie, Shivani Patel, Michele R. Hacker, Dan H. Barouch
Publikováno v:
Reproductive Sciences.
Autor:
Jinyan Liu, Abishek Chandrashekar, Daniel Sellers, Julia Barrett, Catherine Jacob-Dolan, Michelle Lifton, Katherine McMahan, Michaela Sciacca, Haley VanWyk, Cindy Wu, Jingyou Yu, Ai-ris Y. Collier, Dan H. Barouch
Publikováno v:
Nature. 603:493-496
The highly mutated SARS-CoV-2 Omicron (B.1.1.529) variant has been shown to evade a substantial fraction of neutralizing antibody responses elicited by current vaccines that encode the WA1/2020 spike protein1. Cellular immune responses, particularly
Autor:
Ramya Nityanandam, Sofia Lupo, Lori F. Maxfield, Georgia D. Tomaras, Alessandra Setaro, Joseph P. Nkolola, Rebecca Zash, Zhilin Chen, Stephen R. Walsh, Dan H. Barouch, Chelsey Bennett, Lisa Sunner, Tyler Cassidy, Kshitij Wagh, Charlotte-Paige Rolle, Frances Priddy, Erica N. Borducchi, Ana N. Monczor, Jinyan Liu, Roberto C. Arduino, Huub C. Gelderblom, Bryan T. Mayer, Diane G. Kanjilal, Abishek Chandrashekar, Elena E. Giorgi, Nicole L. Yates, Edwin DeJesus, Kathryn E. Stephenson, Alicia Sato, Jessica L Ansel, Michael S. Seaman, Joseph Sapiente, C Sabrina Tan, Alan S. Perelson, Bette T. Korber, Allan C. deCamp, Zijin Lin, Boris Julg, Peter Abbink, Lauren Peter
Publikováno v:
Nature Medicine
Human immunodeficiency virus (HIV)-1-specific broadly neutralizing monoclonal antibodies are currently under development to treat and prevent HIV-1 infection. We performed a single-center, randomized, double-blind, dose-escalation, placebo-controlled
Autor:
Lisa H. Tostanoski, David R. Martinez, Laurent Pessaint, Deandre Bueno-Wilkerson, Felix Nampanya, Jinyan Liu, Abishek Chandrashekar, Daniel Valentin, Frank Wegmann, Katherine McMahan, Anthony L. Cook, Mark G. Lewis, Hanne Leth Andersen, Noe B. Mercado, Victoria M. Giffin, Ralph S. Baric, Renita Brown, Huahua Wan, Sarah Gardner, Caroline Atyeo, Roland Zahn, Galit Alter, Daniel Sellers, Amanda J. Martinot, Zack Flinchbaugh, Tochi Anioke, Shivani A. Patel, Aiquan Chang, Jingyou Yu, Tammy Hayes, Dan H. Barouch, Hanneke Schuitemaker, Owen Sanborn, David L. Hope, Joseph P. Nkolola, Catherine Jacob-Dolan, Esther A. Bondzie, Katherine Bauer, Elyse Teow
Publikováno v:
Nature
The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines1,2. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the WA1/2020 strain of SARS-CoV-2, and
Autor:
John D. Ventura, Joseph P. Nkolola, Abishek Chandrashekar, Erica N. Borducchi, Jinyan Liu, Noe B. Mercado, David L. Hope, Victoria M. Giffin, Katherine McMahan, Romas Geleziunas, Jeffrey P. Murry, Yunling Yang, Mark G. Lewis, Maria G. Pau, Frank Wegmann, Hanneke Schuitemaker, Emily J. Fray, Mithra R. Kumar, Janet D. Siliciano, Robert F. Siliciano, Merlin L. Robb, Nelson L. Michael, Dan H. Barouch
Publikováno v:
npj Vaccines. 7
Developing an intervention that results in virologic control following discontinuation of antiretroviral therapy (ART) is a major objective of HIV-1 cure research. In this study, we investigated the therapeutic efficacy of a vaccine consisting of ade